Skip to content
AnalystLens
Back to NBIXCash Flow

Neurocrine Biosciences Free Cash Flow 2009-2026 | NBIX

Annual FY2009–FY2025 · quarterly through Q3 FY2026

Latest annual · FY2025

$748.7M

+34.4%YoY vs FY2024Source: 10-KFY2025

From −$53.1M in FY2009 to $748.7M in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$137M+152.7%$129M+43.7%$384M+79.0%Not reported
FY25$54M−54.6%$90M+68.9%$214M+43.0%$386M+64.1%
FY24$119M+189.1%$53M−69.3%$150M−26.7%$235M+99.2%
FY23−$134M−178.0%$173M+33.6%$204M+110.5%$118M−16.4%
FY22−$48M−158.1%$129M+30.7%$97M+73.1%$141M+3104.3%
Share14%11%28%47%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+28.0%

FY2020
$217.6M
FY2025
$748.7M

5 years selected · on the chart

Free Cash Flow History

Year-over-year comparison from 10-K annual reports

  1. $748.7M
YoY changeLargest recent move−176.2%in FY16Latest +34.4%

4 older moves run past ±150% (largest −2404.5%); point at, tap or drag across the bars to read one.

Free Cash Flow, period by period

PeriodValueChangeSource
FY2025$748.7M+34.4%10-K
FY2024$557.2M+54.1%10-K
FY2023$361.6M+12.0%10-K
FY2022$322.9M+38.5%10-K
FY2021$233.1M+7.1%10-K
FY2020$217.6M+64.5%10-K
FY2019$132.3M+72.7%10-K
FY2018$76.6M+175.6%10-K
FY2017−$101.3M+8.2%10-K
FY2016−$110.3M−176.2%10-K
FY2015−$39.9M+18.1%10-K
FY2014−$48.8M−61.7%10-K
FY2013−$30.2M+16.9%10-K
FY2012−$36.3M−2404.5%10-K
FY2011−$1.4M−102.9%10-K
FY2010$49.6M+193.4%10-K
FY2009−$53.1M—10-K

What is Neurocrine Biosciences's current free cash flow?

Neurocrine Biosciences (NBIX) annual free cash flow for 2025 was $748.7M, a 34.37% increase from 2024. Neurocrine Biosciences free cash flow for the quarter ending September 30, 2026 was $383.6M.

What was Neurocrine Biosciences's free cash flow in 2024?

Neurocrine Biosciences annual free cash flow for 2024 was $557.2M, a 54.09% increase from 2023.

What was Neurocrine Biosciences's free cash flow in 2023?

Neurocrine Biosciences annual free cash flow for 2023 was $361.6M, a 11.99% increase from 2022.

What is Neurocrine Biosciences's 5-year free cash flow CAGR?

Neurocrine Biosciences free cash flow grew at a compound annual growth rate (CAGR) of 28.04% from FY2020 to FY2025, going from $217.6M to $748.7M over 5 years.

Company
Neurocrine Biosciences
Ticker
NBIX
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)